CLPT
CLPT
NASDAQ · Health Care

Clearpoint Neuro Inc

$11.17
+0.04 (+0.36%)
Financial Highlights (FY 2026)
Revenue
37.27M
Net Income
-25,745,611
Gross Margin
61.4%
Profit Margin
-69.1%
Rev Growth
+21.6%
D/E Ratio
1.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 61.4% 61.4% 53.8% 53.8%
Operating Margin -65.4% -58.8% 16.4% 17.6%
Profit Margin -69.1% -65.6% 15.4% 15.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 37.27M 30.64M 158.88M 142.75M
Gross Profit 22.88M 18.81M 85.53M 76.84M
Operating Income -24,358,588 -18,025,595 26.07M 25.18M
Net Income -25,745,611 -19,052,006 24.47M 21.58M
Gross Margin 61.4% 61.4% 53.8% 53.8%
Operating Margin -65.4% -58.8% 16.4% 17.6%
Profit Margin -69.1% -65.6% 15.4% 15.1%
Rev Growth +21.6% +21.6% +20.9% +17.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 111.11M 111.11M 75.59M 72.54M
Total Equity 63.43M 63.43M 144.13M 160.68M
D/E Ratio 1.75 1.75 0.52 0.45
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,435,496 -19,087,091 37.89M 33.02M
Free Cash Flow 31.87M 21.95M